How Biotech Companies Stay Competitive With M&A Strategies

This week's Fierce Pharma Marketing is brought to you by AlphaSense.

Deal or No Deal: How Biotech Companies Stay Competitive With M&A Strategies

Thursday, April 21, 2022 | 11am ET / 8am PT

While there is no shortage of innovation in biotech, there are still major challenges faced by all companies. Within the evolving drug development landscape, it’s no surprise that external innovation through partnerships and acquisitions is a critical part of the biotech ecosystem. We are thrilled to have Dr. Yaron Werber join us to share a behind-the-scenes look at what goes on before and after deals reach the negotiating table.

You’ll walk away with: